<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210201050212N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-28</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>The effect of yarrow on menopause</public_title>
      <acronym></acronym>
      <scientific_title>Investigation of the Comparative Effectiveness Between Achillea wilhelmsii Consumption and Counseling with Mindfulness-Based Cognitive Therapy (MBCT)ََApproach on Hot Flashes, Quality of Life and Sleep in Menopausal Women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54059</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Random permutation will be performed using the block method: For random assignment, triple blocks with three patients and a table of single-digit random numbers are used, so that for a random number, a triple block, and for a random number, two triple blocks, and so on, the numbers zero, seven, and eight are used. No, we will.
ABC for digit 1
ACB for figure 2
BAC for digit 3
BCA for figure 4
CAB for digit 5
CBA for figure 6
And we ignore the numbers 0, 7, 8 and 9.
The reason for using the random permutation block method is that the number of people in the groups is equal.</study_design>
      <phase>2</phase>
      <hc_freetext>Condition 1: Investigation of the comparative effectiveness between Achillea wilhelmsii consumption and counseling with mindfulness-based cognitive therapy (MBCT) approach on hot flashes,  in menopausal women. Condition 2: Comparative study of the effect of  Achillea wilhelmsii  and counseling with mindfulness-based cognitive therapy approach on quality of life in postmenopausal women. Condition 3: Comparative study of the effect of  Achillea wilhelmsii  and counseling with mindfulness-based cognitive therapy approach on sleep quality in postmenopausal women.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Achillea wilhelmsii  capsule (2 mg daily in the morning and evening for 2 months) which contains  Achillea wilhelmsii which has phytoestrogenic properties and is produced by Kerman School of Pharmacy. Intervention 2: Intervention group: Counseling group:Eight sessions of 120 to 150 minutes. With 45 minutes a day of exercise, which can be accompanied by a one-day program of mindfulness guided in week 6. In the first 4 sessions, the focus is on inner experiences and in the second half on the challenges of life. Mindfulness training will be short. Intervention 3: Control group: Does not receive any intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Omolbanin Lotfi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.1,GHarani Ave,Torbat Heydariyeh University of Medical Sciences</address>
        <city>Torbat heydarieh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9516717311</zip>
        <telephone>+98 51 5222 7100</telephone>
        <email>o.lotfi1398@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Omolbanin Lotfi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.1,GHarani Ave,Torbat Heydariyeh University of Medical Sciences</address>
        <city>Torbat heydarieh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9516717311</zip>
        <telephone>+98 51 5222 7100</telephone>
        <email>o.lotfi1398@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Be literate
All Women are 65-45
Have at least 3- 20 hot flashes a day
For one year after the last menstrual period</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Absence from two sessions of medical counseling
Have a physical or mental illness
Have a regular exercise program
Taking psychotropic drugs
Have a severely stressful event over the past month
Has taken less than 80% of his medication
Has used soy or phytoestrogens more than once in the past week
Over the past week with a specific illness that is severely stressful or causing pain
During the study, he had to use a special medication that caused sleep disturbances as well as hot flashes
Have changed your sleeping place and place during the last week
Used sleeping pills or hypnotics
He has used psychedelic, sedative and anti-anxiety drugs
Be addicted to drugs such as cigarettes and alcohol
Use medications that cause sleep disturbances or insomnia
History of yarrow or any of its components, people with allergic asthma, seizures, liver disease or cancer
Take any estrogen-based medication to treat menopausal complications (osteoporosis, hot flashes) or other interfering medications such as tibolone with a night shift job.
Menopause due to bilateral removal of the ovaries or undergoing chemotherapy
Treatment for mental disorders or hot flashes in the last 60 days
Hormone Therapy
Use of hormonal contraceptives
Taking selective estrogen receptor modulators or aromatase inhibitors over the past two months
Have severe depression
Have a severe current illness
Suicide attempt in the last 3 weeks
Having bipolar disorder or other mental disorders throughout life
Uncontrolled blood pressure
Taking tamoxifen, raloxifene, antidepressant, clonidine in the last two months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Achillea wilhelmsii  capsule (2 mg daily in the morning and evening for 2 months) which contains  Achillea wilhelmsii which has phytoestrogenic properties and is produced by Kerman School of Pharmacy</i_keyword>
      <i_keyword>Intervention group: Counseling group:Eight sessions of 120 to 150 minutes. With 45 minutes a day of exercise, which can be accompanied by a one-day program of mindfulness guided in week 6. In the first 4 sessions, the focus is on inner experiences and in the second half on the challenges of life. Mindfulness training will be short.</i_keyword>
      <i_keyword>Control group: Does not receive any intervention</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Flush score. Timepoint: Measure hot flashes before the study and at the end of the first and second months. Method of measurement: Flushing severity questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-14</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>No.9,Kashini Ave Totbat e heydarieh Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
